Beta-Blockers for Anxiety: What the Evidence Actually Supports
What research shows about beta-blockers (propranolol) for anxiety, where the evidence is strongest, and why off-label use has outpaced the trial data.
What research shows about beta-blockers (propranolol) for anxiety, where the evidence is strongest, and why off-label use has outpaced the trial data.
What randomized trials show about progressive muscle relaxation for anxiety, how it compares with other approaches, and where the evidence is strong versus weak.
What ecological momentary assessment is, how it differs from retrospective questionnaires, what it has revealed about anxiety that standard measures miss, and its limitations.
What research shows about breathing techniques for anxiety, which mechanisms are supported, and why the evidence is better for acute relief than lasting change.
What randomized trials show about internet-delivered CBT for anxiety versus face-to-face therapy, where the evidence is strong, and what gaps remain.
How common dropout is in anxiety therapy trials and clinical practice, what predicts it, why it matters for interpreting treatment evidence, and what it means for individual decisions.
What longitudinal studies reveal about childhood temperament, adversity, parenting, and other predictors of anxiety disorders, and why prediction is weaker than it sounds.
How different study designs produce different conclusions about social media and anxiety, why most research can't establish causation, and what the best evidence shows.
Why studies linking screen time to anxiety are mostly correlational, what the effect sizes are, and why the causal story is more complicated than headlines suggest.
What floor and ceiling effects are in anxiety measurement, which common scales are vulnerable, how these effects distort treatment research, and what alternatives exist.